Skip to Content Skip to Main Content Skip to Navigation
You are using an outdated browser. Please upgrade your browser to improve your experience and security.
  • Our Funds

    Discover our Funds

    • Growth Equities
    View All
  • Insights

    Investment Insights

    • Articles
    • Podcasts
    View All

    Latest Insights

    Fast Growing BROS
    Fast Growing BROS
    Paypal
    PayPal, Accepted Here….(at a big discount)
    Circular economy stock comes full circle
Fiftyone Logo Fiftyone Logo
  • About
  • Contact
Close
  • Our Funds
  • Insights
  • Performance Updates
  • About
  • Careers
  • Contact Us
Back

18 March 2021 Fiftyone Capital Podcasts Time: 1hr and 28min podcast

An In Depth Interview with Paul Rennie from PAR

We sat down for a longform, in-depth discussion with Paul Rennie from Paradigm Biopharmaceuticals. PAR has been a core holding for Fiftyone Capital almost from inception and we foresee some major catalysts ahead for the company. The information in this podcast is strictly general in nature and is not advice or based on your personal situation. Do your own research.
Play: 1hr and 28min
Presented by

Greg Wheatley

Listen on
PodBean
More Episodes

That’s the way the crypto crumbles…

Episode 27

FOMO and 5G

Episode 26

If you thought 2020 was crazy……

Episode 25

PAR Update #3

Subscribe to receive the latest updates from Fiftyone Capital.

Fields marked with * are required.
This field is for validation purposes and should be left unchanged.
Our Office
+61 8 6118 2777

Ground Floor,
105 Forrest Street
Cottesloe WA 6011

Fiftyone Capital |
ABN 57 651 230 232

WACC Pty Ltd |
ACN 626 888 944
AFSL 509628

Fiftyone Logo Fiftyone Logo
Discover
  • Our Funds
  • Insights
  • About
  • Careers
  • Contact Us
  • Performance Updates
Connect with us
  • Twitter
  • Linkedin
Subscribe
Fields marked with * are required.
This field is for validation purposes and should be left unchanged.

© 2022 Fiftyone

  • Privacy Policy
Site by Juicebox